Laura Sepp-lorenzino - Net Worth and Insider Trading

Laura Sepp-lorenzino Net Worth

The estimated net worth of Laura Sepp-lorenzino is at least $669,887 dollars as of 2024-11-05. Laura Sepp-lorenzino is the EVP, Chief Scientific Officer of Intellia Therapeutics Inc and owns about 43,927 shares of Intellia Therapeutics Inc (NTLA) stock worth over $669,887. Details can be seen in Laura Sepp-lorenzino's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Laura Sepp-lorenzino has not made any transactions after 2024-01-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Laura Sepp-lorenzino

To

Laura Sepp-lorenzino Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Laura Sepp-lorenzino owns 2 companies in total, including Intellia Therapeutics Inc (NTLA) , and Taysha Gene Therapies Inc (TSHA) .

Click here to see the complete history of Laura Sepp-lorenzino’s form 4 insider trades.

Insider Ownership Summary of Laura Sepp-lorenzino

Ticker Comapny Transaction Date Type of Owner
NTLA Intellia Therapeutics Inc 2024-01-08 EVP & Chief Scientific Officer
TSHA Taysha Gene Therapies Inc 2020-11-23 director

Laura Sepp-lorenzino Latest Holdings Summary

Laura Sepp-lorenzino currently owns a total of 1 stock. Laura Sepp-lorenzino owns 43,927 shares of Intellia Therapeutics Inc (NTLA) as of January 8, 2024, with a value of $669,887.

Latest Holdings of Laura Sepp-lorenzino

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NTLA Intellia Therapeutics Inc 2024-01-08 43,927 15.25 669,887

Holding Weightings of Laura Sepp-lorenzino


Laura Sepp-lorenzino Form 4 Trading Tracker

According to the SEC Form 4 filings, Laura Sepp-lorenzino has made a total of 6 transactions in Intellia Therapeutics Inc (NTLA) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Intellia Therapeutics Inc is the sale of 2,275 shares on January 8, 2024, which brought Laura Sepp-lorenzino around $65,679.

Insider Trading History of Laura Sepp-lorenzino

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Laura Sepp-lorenzino Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Laura Sepp-lorenzino Ownership Network

Ownership Network List of Laura Sepp-lorenzino

No Data

Ownership Network Relation of Laura Sepp-lorenzino

Insider Network Chart

Laura Sepp-lorenzino Owned Company Details

What does Intellia Therapeutics Inc do?

Who are the key executives at Intellia Therapeutics Inc?

Laura Sepp-lorenzino is the EVP & Chief Scientific Officer of Intellia Therapeutics Inc. Other key executives at Intellia Therapeutics Inc include EVP & Chief Technical Officer Eliana Clark , EVP & Chief Business Officer Derek Hicks , and director & President and CEO John M. Leonard .

Intellia Therapeutics Inc (NTLA) Insider Trades Summary

Over the past 18 months, Laura Sepp-lorenzino made 2 insider transaction in Intellia Therapeutics Inc (NTLA) with a net sale of 7,807. Other recent insider transactions involving Intellia Therapeutics Inc (NTLA) include a net sale of 10,373 shares made by Eliana Clark , a net sale of 2,397 shares made by Muna Bhanji , and a net sale of 19,223 shares made by John M. Leonard .

In summary, during the past 3 months, insiders sold 2,012 shares of Intellia Therapeutics Inc (NTLA) in total and bought 0 shares, with a net sale of 2,012 shares. During the past 18 months, 62,207 shares of Intellia Therapeutics Inc (NTLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 62,207 shares.

Intellia Therapeutics Inc (NTLA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Intellia Therapeutics Inc Insider Transactions

No Available Data

Laura Sepp-lorenzino Mailing Address

Above is the net worth, insider trading, and ownership report for Laura Sepp-lorenzino. You might contact Laura Sepp-lorenzino via mailing address: C/o Intellia Therapeutics, Inc., 40 Erie Street, Suite 130, Cambridge Ma 02139.